June 24, 2025

Immunocore Holdings plc (IMCR) Stock Analysis: Exploring the 99.81% Potential Upside

Immunocore Holdings plc (NASDAQ: IMCR), a United Kingdom-based biotechnology company, is making waves in the healthcare sector, drawing significant attention from investors with its promising pipeline..

Pulse Biosciences, Inc (PLSE) Stock Analysis: Understanding the Healthcare Innovator’s Growth Potential

In the rapidly evolving landscape of healthcare technology, Pulse Biosciences, Inc. (NASDAQ: PLSE) stands out as a pioneering force with its innovative bioelectric medicine solutions. With..

CONMED Corporation (CNMD) Stock Analysis: Evaluating a 28.89% Potential Upside for Investors

CONMED Corporation (NYSE: CNMD), a prominent player in the healthcare sector specializing in medical devices, presents a compelling investment opportunity with a potential upside of 28.89%...

Vericel Corporation (VCEL) Stock Analysis: Unpacking a 42% Potential Upside

Investors eyeing the biotechnology sector may find Vericel Corporation (NASDAQ: VCEL) an intriguing prospect, especially given its promising 42.05% potential upside. This U.S.-based healthcare company, with..

Astrana Health Inc. (ASTH) Stock Analysis: A Healthcare Contender with 91% Potential Upside

Astrana Health Inc. (NASDAQ: ASTH), a prominent player in the healthcare sector, is attracting considerable attention from investors due to its significant growth potential. With a..

Pacira BioSciences (PCRX) Stock Analysis: Exploring a 22.88% Upside in the Non-Opioid Pain Management Sector

Pacira BioSciences, Inc. (NASDAQ: PCRX) stands at the forefront of the healthcare sector, particularly within the specialty drug manufacturing industry. With a market capitalization of $1.15..

MannKind Corporation (MNKD) Stock Analysis: Unlocking a Potential 148% Upside in the Biotech Industry

MannKind Corporation (NASDAQ: MNKD), a biopharmaceutical company focused on innovative therapeutic solutions for endocrine and orphan lung diseases, is capturing investor attention within the healthcare sector...

Adaptive Biotechnologies (ADPT) Stock Analysis: A Promising Biotech with 12.28% Upside Potential

Adaptive Biotechnologies Corporation (NASDAQ: ADPT) is drawing considerable attention from investors, particularly due to its potential upside of 12.28%, as indicated by analysts. Operating in the..

Harmony Biosciences Holdings, Inc. (HRMY) Stock Analysis: A Promising 61% Potential Upside for Investors

Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY) is making waves in the biotech sector with its promising therapies for rare and neurological diseases. This commercial-stage pharmaceutical company,..

Envista Holdings Corp (NVST) Stock Analysis: Navigating Challenges with Strategic Positioning in the Dental Market

Envista Holdings Corporation (NYSE: NVST) stands at a crossroads in the healthcare sector, particularly within the medical instruments and supplies industry. With a current market capitalization..

BGM Group Ltd. (BGM): Stock Analysis Reveals Challenges Amid Revenue Decline in Healthcare Sector

BGM Group Ltd. (BGM), a player in the Healthcare sector, specifically within the Drug Manufacturers – Specialty & Generic industry in China, has caught the attention..

GoodRx Holdings, Inc. (GDRX) Stock Analysis: Exploring a 34.68% Potential Upside in Healthcare Savings

GoodRx Holdings, Inc. (NASDAQ: GDRX) has carved a niche in the healthcare sector by providing a vital service: enabling consumers to save on prescription drug purchases..

PROCEPT BioRobotics (PRCT) Stock Analysis: A 30.87% Potential Upside in the Healthcare Robotics Market

PROCEPT BioRobotics Corporation (NASDAQ: PRCT) stands as a cutting-edge leader in the medical devices sector, specifically within the realm of surgical robotics. Headquartered in San Jose,..

89bio, Inc. (ETNB) Stock Analysis: Eyeing a 194.55% Upside Potential

For investors with an appetite for high-risk, high-reward opportunities, 89bio, Inc. (NASDAQ: ETNB) presents an intriguing prospect within the biotechnology sector. Headquartered in San Francisco, this..

LeMaitre Vascular, Inc. (LMAT) Stock Analysis: Unpacking the 25% Potential Upside in the Healthcare Sector

LeMaitre Vascular, Inc. (NASDAQ: LMAT) stands out in the healthcare sector with a unique focus on developing, manufacturing, and marketing medical devices for vascular surgery. With..

Amicus Therapeutics, Inc. (FOLD) Stock Analysis: A Potential 177% Upside in the Biotech Sector

Amicus Therapeutics, Inc. (NASDAQ: FOLD) is making waves in the biotechnology sector with its focus on rare diseases. This Princeton, New Jersey-based company is attracting significant..

Dynavax Technologies Corporation (DVAX) Stock Analysis: Exploring a 138% Potential Upside Amidst Innovative Vaccine Developments

Dynavax Technologies Corporation (NASDAQ: DVAX), a biopharmaceutical company based in Emeryville, California, presents a riveting investment opportunity in the healthcare sector. With a market capitalization of..

Arcellx, Inc. (ACLX) Stock Analysis: Biotechnology Innovator with a Robust 74.68% Potential Upside

Arcellx, Inc. (NASDAQ: ACLX) is capturing attention with its ambitious strides in the biotechnology sector, particularly in the field of cancer immunotherapy. Specializing in developing innovative..

Protagonist Therapeutics, Inc. (PTGX) Stock Analysis: A Biotech Contender with a 29% Upside Potential

Protagonist Therapeutics, Inc. (NASDAQ: PTGX) is capturing investor attention with its promising pipeline in the biotechnology sector, particularly in the realm of peptide therapeutics for hematology,..

Neogen Corporation (NEOG) Stock Analysis: Exploring an 88.68% Potential Upside

Neogen Corporation (NASDAQ: NEOG), a prominent player in the healthcare sector’s Diagnostics & Research industry, has recently caught the attention of investors, with an exciting 88.68%..

Search

Funds

June 24, 2025

Search

Funds

June 24, 2025

FTSE 100

Funds